|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.18 EUR | -0.11% |
|
+2.19% | +9.98% |
| 06-23 | Orion's Investigational Drug Wins EU Orphan Drug Designation to Treat Malignant Mesothelioma | MT |
| 06-16 | Digia Unit to Provide Data Integration, AI Analytics for Finnish Health Sector Project | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 11.26B | |||||
| 1,006B | |||||
| 589B | |||||
| 430B | |||||
| 331B | |||||
| 288B |
- Stock Market
- Stocks
- ORNBV Stock
- Charts Orion Oyj
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
